Loading clinical trials...

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | Clinical Trials | Clareo Health

Back to clinical trial search

Enrolling By InvitationPhase 3NCT04326426

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

This is a randomized, double-blind placebo-controlled trial to investigate the efficacy and safety of tradipitant 85 mg orally given twice daily to treat inflammatory lung injury associated with sever...

Lead sponsor: Vanda Pharmaceuticals•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

RECRUITING

In-depth Immunological Investigation of COVID-19.

NCT04327570 · Coronavirus Infections

RECRUITING

Post COVID-19 Biorepository

NCT04885504 · Coronavirus Infection

RECRUITING

Capturing MultiORgan Effects of COVID-19

NCT04510025 · Coronavirus Infection, Multi-Organ Disorder

Active Not Recruiting

French COVID Cohort

NCT04262921 · Coronavirus Infections

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 20, 2020Terms

Trial snapshot

StatusENROLLING_BY_INVITATION

PhasePHASE3

Enrollment300

Start dateApr 2020

Last updatedApr 20, 2020

Condition

Coronavirus Infection

Locations shown

Lenox Hill Hospital Northwell Health

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 20, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

In-depth Immunological Investigation of COVID-19.

Post COVID-19 Biorepository

Capturing MultiORgan Effects of COVID-19

French COVID Cohort

Trial snapshot

Condition

Locations shown

For caregivers